Atri Pharma Research (India) Private Limited
About Atri Pharma Research (India) Private Limited
Data last updated:
Atri Pharma Research (India) Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Ras Global Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2009PTC062684.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹47.78 Lakh. It is led by directors Santosh Varalwar and Nixon Patel.
Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.181 Industrial Development Area (Ida) Mallapur, Hyderabad, Telangana, India – 500076.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Atri Pharma Research (India) has one previous CIN (Corporate Identification Number): U73100AP2009PTC062684. The current CIN is U73100TG2009PTC062684, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2009PTC062684 | Current |
| U73100AP2009PTC062684 | Previous |
Contact details
Atri Pharma Research (India) Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.181 Industrial Development Area (Ida) Mallapur, Hyderabad, Telangana, India – 500076
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Atri Pharma Research (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Atri Pharma Research (India) Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atri Pharma Research (India) Private Limited, buy the company report.
Board of directors of Atri Pharma Research (India) Private Limited
Atri Pharma Research (India) has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Varalwar Also directs: B B R Projects Private Limited, Uquifa India Private Limited, Kreative Hosts Atria Private Limited and 1 more | Director | 02 Feb 2009 | 17 Years 9 Months | Current |
| Nixon Patel Also directs: Qcarbon Materials Private Limited | Director | 02 Feb 2009 | 17 Years 9 Months | Current |
Auditor
Atri Pharma Research (India) Private Limited is audited by P MURALI & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P MURALI & ASSOCIATES | FY 2020 | 002080S |
Shareholding
The shareholding of Atri Pharma Research (India) Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Atri Pharma Research (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Atri Pharma Research (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atri Pharma Research (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Atri Pharma Research (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Atri Pharma Research (India) Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Nixon Patel was appointed as Director on 02 Feb 2009.
Frequently asked questions
Atri Pharma Research (India) is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 2009 (17+ years old) and is registered under CIN U73100TG2009PTC062684.
Atri Pharma Research (India) has 2 current directors:
- Santosh Varalwar - Director
- Nixon Patel - Director
The latest financial statements of Atri Pharma Research (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Atri Pharma Research (India) is U73100TG2009PTC062684. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atri Pharma Research (India) was incorporated on 02 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nixon Patel was appointed as Director on 02 Feb 2009. Santosh Varalwar was appointed as Director on 02 Feb 2009.
The registered office of Atri Pharma Research (India) is at Plot No.181 Industrial Development Area Ida Mallapur, Hyderabad, Telangana, India – 500076.
Atri Pharma Research (India) operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Atri Pharma Research (India) is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.
Atri Pharma Research (India) can be reached at its registered office: Plot No.181 Industrial Development Area Ida Mallapur, Hyderabad, Telangana, India – 500076.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
